Work

Predicting early relapse in patients with BRAFV600E melanoma with a highly sensitive blood BRAF assay.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.8516

Authors: Ryan J. Sullivan, Donald P. Lawrence, Keith T. Flaherty, David F. McDermott, Julie Aldridge, Daniel C. Cho, Rachel Simonson, Virginia Jean Seery, F. Stephen Hodi, Michael B. Atkins, James Walter Mier, David J Panka

Institutions: Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2964197355

Cites:

Cited by: 3

Related to: 10